Sodium Tungstate Promotes Neurite Outgrowth and Confers Neuroprotection in Neuro2a and SH-SY5Y Cells
Sodium tungstate (Na<sub>2</sub>WO<sub>4</sub>) normalizes glucose metabolism in the liver and muscle, activating the Mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway. Because this pathway controls neuronal survival and differentiation, we investigated the effects of Na<sub>2</sub>WO<sub>4</sub> in mouse Neuro2a and human SH-SY5Y neuroblastoma monolayer cell cultures. Na<sub>2</sub>WO<sub>4</sub> promotes differentiation to cholinergic neurites via an increased G1/G0 cell cycle in response to the synergic activation of the Phosphatidylinositol 3-kinase (PI3K/Akt) and ERK1/2 signaling pathways. In Neuro2a cells, Na<sub>2</sub>WO<sub>4</sub> increases protein synthesis by activating the mechanistic target of rapamycin (mTOR) and S6K kinases and GLUT3-mediated glucose uptake, providing the energy and protein synthesis needed for neurite outgrowth. Furthermore, Na<sub>2</sub>WO<sub>4</sub> increased the expression of myocyte enhancer factor 2D (MEF2D), a member of a family of transcription factors involved in neuronal survival and plasticity, through a post-translational mechanism that increases its half-life. Site-directed mutations of residues involved in the sumoylation of the protein abrogated the positive effects of Na<sub>2</sub>WO<sub>4</sub> on the MEF2D-dependent transcriptional activity. In addition, the neuroprotective effects of Na<sub>2</sub>WO<sub>4</sub> were evaluated in the presence of advanced glycation end products (AGEs). AGEs diminished neurite differentiation owing to a reduction in the G1/G0 cell cycle, concomitant with lower expression of MEF2D and the GLUT3 transporter. These negative effects were corrected in both cell lines after incubation with Na<sub>2</sub>WO<sub>4.</sub> These findings support the role of Na<sub>2</sub>WO<sub>4</sub> in neuronal plasticity, albeit further experiments using 3D cultures, and animal models will be needed to validate the therapeutic potential of the compound.
Authors
- Rafael Salto (ORCID: https://orcid.org/0000-0002-7044-3611)
- María D. Girón (ORCID: https://orcid.org/0000-0001-9638-988X)
- José Rienda (ORCID: https://orcid.org/0000-0003-3256-8525)
- Nora Montero-Martin
Institutions
- Universidad de Granada (ES)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2024-08-23
- DOI
- https://doi.org/10.3390/ijms25179150
- Citations
- 2
- Primary Topic
- Neurogenesis and neuroplasticity mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.82
Funders
- Universidad de Granada